fda semaglutide warning warns Novo Nordisk for not reporting deadly side effects FBI issues safety warning about

MHRA approves first dual GIP and GLP-1 receptor agonist Mounjaro (tirzepatide) for weight management

M.DoukovT.PowersA

Obesity-related cancers identified in the IARC study include endometrial, esophageal, renal cell, gastric, pancreas, colon/rectal, gallbladder, breast, ovarian, and thyroid cancers as well as meningioma, multiple myeloma

Low levels of glutathione can result in various deficiencies and problems in the body

Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works through dual GIP and GLP-1 receptor activation

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth